![Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups | Semantic Scholar Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8f4b0d890428d2d1d31b6df02ec1166b1a934a81/3-Figure1-1.png)
Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups | Semantic Scholar
![Successful Management of a Black Male With Psoriasis and Dyspigmentation Treated With Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion: Case Report | Skin of Color Update | Dermatology Conference | New York City Successful Management of a Black Male With Psoriasis and Dyspigmentation Treated With Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion: Case Report | Skin of Color Update | Dermatology Conference | New York City](https://skinofcolorupdate.com/wp-content/uploads/2021/04/SOC_JDDCaseReport_April.png)
Successful Management of a Black Male With Psoriasis and Dyspigmentation Treated With Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion: Case Report | Skin of Color Update | Dermatology Conference | New York City
![Psoriasis in Patients of Color: Differences in Morphology, Clinical Presentation, and Treatment | MDedge Dermatology Psoriasis in Patients of Color: Differences in Morphology, Clinical Presentation, and Treatment | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/CT106002007_SI_Fig1_AB.jpg)